SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-001293
Filing Date
2023-01-12
Accepted
2023-01-12 16:05:13
Documents
15
Period of Report
2023-01-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47849
2 ex5.htm EX-5 17539
3 ex5_001.jpg GRAPHIC 2230
  Complete submission text file 0001493152-23-001293.txt   299615

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hrow-20230111.xsd EX-101.SCH 4149
5 XBRL DEFINITION FILE hrow-20230111_def.xml EX-101.DEF 27404
6 XBRL LABEL FILE hrow-20230111_lab.xml EX-101.LAB 37859
7 XBRL PRESENTATION FILE hrow-20230111_pre.xml EX-101.PRE 26021
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6499
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 23525989
SIC: 2834 Pharmaceutical Preparations